Adding Tukysa to Standard of Care Continues To Improve Survival in Advanced-Stage HER2-Positive Breast Cancer June 15, 2021 Adding Tukysa to the standard of care of Herceptin and Xeloda continued to improve both progression-free and overall survival in people diagnosed with either metastatic or unresectable locally…
I am newly diagnosed with ER+++/HER2+++ and in doing research I found several studies that cite Omega 3 supplements -- specifically EPA and DHA -- that are being shown to reduce the risk of breast cancer and reduce the size of tumors. I am wondering if anyone else has read about this or taking these supplements. "The team…
Virginia was at the end of her treatment options when she learned of the Herceptin trials and volunteered. Dr Slamons and Dr shepherd who developed the drug also appear in this short video https://youtu.be/QFXVprOlu84